Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Sodium Oxybate in Idiopathic Hypersomnia
NCT05837091Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Feb 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in idiopathic hypersomnia (IH), sponsored by Mayo Clinic. Started Feb 2024; status: recruiting.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
idiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT05837091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837091.